NorthWest Biotherapeutics Inc (NWBO)

[Dr Bala]

The UCLA Combo Project I Trial uses DCVax-L. Here is the UCLA link (courtesy of moderation23) that says that UCLA uses DCVax-L:
https://cancer.ucla.edu/research/ucla-brain-spore/research-projects

Finally, in Aim 3, we will develop and validate predictive tumor, immunological and imaging biomarkers of response in recurrent glioblastoma patients enrolled in a Phase II clinical trial of DCVax-L +/- PD-1 blockade.